Filtrovat podle Last updated date SelectpopředFrom - To Datum Datum ukončení Tento týden Tento měsíc Minulý týden Minulý měsíc Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Výsledky (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA starts rolling review of the Sputnik V COVID-19 vaccine 4 Březen 2021 News Human COVID-19 Vaccines EMA review of regdanvimab for COVID-19 to support national decisions on early use 2 Březen 2021 News Human COVID-19 Medicines EMA and Health Canada publish clinical data used to support their authorisations of the Moderna COVID-19 vaccine 2 Březen 2021 News Human COVID-19 Vaccines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 February 2021 26 Únor 2021 News Human COVID-19 Biosimilars Generic and hybrid medicines Medicines Referrals First oral treatment for spinal muscular atrophy (SMA) recommended for approval 26 Únor 2021 News Human Medicines EMA issues advice on use of REGN-COV2 antibody combination (casirivimab / imdevimab) 26 Únor 2021 News Human COVID-19 Medicines Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers 25 Únor 2021 News Human COVID-19 Regulatory and procedural guidance Vaccines International cooperation to align approaches for regulation of COVID-19 vaccines and medicines 25 Únor 2021 News Human COVID-19 Medicines Vaccines EMA starts rolling review of Celltrion antibody regdanvimab for COVID-19 24 Únor 2021 News Human COVID-19 Medicines EMA starts evaluating use of Veklury in COVID-19 patients not requiring supplemental oxygen 23 Únor 2021 News Human COVID-19 1 … 66 67 68 69 70 Page 70 of 380 71 72 73 74 … 380
EMA starts rolling review of the Sputnik V COVID-19 vaccine 4 Březen 2021 News Human COVID-19 Vaccines
EMA review of regdanvimab for COVID-19 to support national decisions on early use 2 Březen 2021 News Human COVID-19 Medicines
EMA and Health Canada publish clinical data used to support their authorisations of the Moderna COVID-19 vaccine 2 Březen 2021 News Human COVID-19 Vaccines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 February 2021 26 Únor 2021 News Human COVID-19 Biosimilars Generic and hybrid medicines Medicines Referrals
First oral treatment for spinal muscular atrophy (SMA) recommended for approval 26 Únor 2021 News Human Medicines
EMA issues advice on use of REGN-COV2 antibody combination (casirivimab / imdevimab) 26 Únor 2021 News Human COVID-19 Medicines
Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers 25 Únor 2021 News Human COVID-19 Regulatory and procedural guidance Vaccines
International cooperation to align approaches for regulation of COVID-19 vaccines and medicines 25 Únor 2021 News Human COVID-19 Medicines Vaccines
EMA starts rolling review of Celltrion antibody regdanvimab for COVID-19 24 Únor 2021 News Human COVID-19 Medicines
EMA starts evaluating use of Veklury in COVID-19 patients not requiring supplemental oxygen 23 Únor 2021 News Human COVID-19